|Bid||39.91 x 1100|
|Ask||44.19 x 900|
|Day's range||41.06 - 42.91|
|52-week range||37.60 - 52.03|
|Beta (5Y monthly)||1.64|
|PE ratio (TTM)||21.88|
|Earnings date||01 Aug 2022 - 05 Aug 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||55.38|
Does the May share price for Envista Holdings Corporation ( NYSE:NVST ) reflect what it's really worth? Today, we will...
Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in Stifel 2022 Jaws & Paws Conference on Wednesday, June 1, 2022, from 9:45 – 10:15 AM EST in New York, New York.
Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced it has entered into a definitive agreement to acquire Osteogenics Biomedical Inc, Allotech LLC and OBI Biologics, Inc (together "Osteogenics"). The transaction is subject to customary regulatory approvals and expected to close in the Third Quarter.